Document Viewer
Declining sales force, revenue send Avon shares tumbling
Feb 16

Editors Note Updates with detail, comparison to same period last year. With AP Photos.

NEW YORK (AP) _ Shares in Avon Products plunged 20 percent as sales at the cosmetics company continued a long slide and the number of people selling them declined.

There were 2 percent fewer people selling Avon products during the quarter.

Sales have declined every year since 2012, and fell 8 percent in 2016.

For the fourth quarter, Avon reported a loss of $10.7 million, or 4 cents per share.

Adjusted for expenses, the company made one penny per share, far worse than the per-share earnings of 9 cents that Wall Street had expected, according to a survey by Zacks Investment Research.

Its revenue of $1.57 billion was just short of the $1.6 billion industry analysts had projected.

In early 2016, the company initiated a three-year plan to revitalize the brand and cut costs. In March, it announced 2,500 job cuts and said that it would move its headquarters from New York to Great Britain.

On Thursday, Avon said that it had realized an estimated $120 million of savings last year. It said that it exceeded its goal of cutting $250 million in debt by $10 million.

For the year, the company reported that its loss narrowed to $107.6 million, or 29 cents per share. Revenue was $5.72 billion.


Elements of this story were generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on H at

By The Associated Press, Copyright 2017

Simmons Hanly Conroy files lawsuits against drug companies over opioids marketing

    NEW YORK – Simmons Hanly Conroy, one of the nation’s largest law firms focused on consumer protection and mass tort actions, has filed lawsuits on behalf of New York’s Broome and Erie counties against pharmaceutical companies and physicians over what is being called aggressive and fraudulent marketing of prescription opium-like painkillers (opioids) that has led to a drug epidemic in the counties.
    In complaints filed Feb. 1 in the New York Supreme Court, the counties seek relief including compensatory and punitive damages for the millions of dollars they spend each year to combat the public nuisance created by the drug companies’ deceptive marketing campaign that misrepresents the safety and efficacy of long-term opioid use. The lawsuits follow a similar, ongoing action filed by Simmons Hanly Conroy in August 2016 on behalf of Suffolk County, N.Y.

Click Here for Full Story